Cargando…

Epidemiology of Post-Kala-azar Dermal Leishmaniasis

Post-kala-azar dermal leishmaniasis (PKDL) is a cutaneous sequel of visceral leishmaniasis (VL) or kala-azar and has become an entity of epidemiological significance by virtue of its ability to maintain the disease in circulation during inter-epidemic periods. PKDL has been identified as one of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosh, Pramit, Roy, Pritam, Chaudhuri, Surya Jyati, Das, Nilay Kanti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061485/
https://www.ncbi.nlm.nih.gov/pubmed/33911289
http://dx.doi.org/10.4103/ijd.IJD_651_20
_version_ 1783681576487354368
author Ghosh, Pramit
Roy, Pritam
Chaudhuri, Surya Jyati
Das, Nilay Kanti
author_facet Ghosh, Pramit
Roy, Pritam
Chaudhuri, Surya Jyati
Das, Nilay Kanti
author_sort Ghosh, Pramit
collection PubMed
description Post-kala-azar dermal leishmaniasis (PKDL) is a cutaneous sequel of visceral leishmaniasis (VL) or kala-azar and has become an entity of epidemiological significance by virtue of its ability to maintain the disease in circulation during inter-epidemic periods. PKDL has been identified as one of the epidemiological marker of “kala-azar elimination programme.” Data obtained in 2018 showed PKDL distribution primarily concentrated in 6 countries, which includes India, Sudan, south Sudan, Bangladesh, Ethiopia, and Nepal in decreasing order of case-burden. In India, PKDL cases are mainly found in 54 districts, of which 33 are in Bihar, 11 in West Bengal, 4 in Jharkhand, and 6 in Uttar Pradesh. In West Bengal the districts reporting cases of PKDL cases include Darjeeling, Uttar Dinajpur, Dakshin Dinajpur, Malda, and Murshidabad. The vulnerability on the young age is documented in various studies. The studies also highlights a male predominance of the disease but recent active surveillance suggested that macular form of PKDL shows female-predominance. It is recommended that along with passive case detection, active survey helps in early identification of cases, thus reducing disease transmission in the community. The Accelerated plan for Kala-azar elimination in 2017 introduced by Government of India with the goal to eliminate Kala-azar as a public health problem, targets to reduceing annual incidence <1/10,000. Leishmania donovani is the established causative agent, but others like L. tropica or L. infantum may occasionally lead to the disease, especially with HIV-co-infection. Dermal tropism of the parasite has been attributed to overexpression of parasite surface receptors (like gp 63, gp46). Various host factors are also identified to contribute to the development of the disease, including high pretreatment IL 10 and parasite level, inadequate dose and duration of treatment, malnutrition, immuno-suppression, decreased interferon-gamma receptor 1 gene, etc. PKDL is mostly concentrated in the plains below an altitude of 600 mts which is attributed to the environment conducive for the vector sand fly (Phlebotumus). Risk factors are also linked to the habitat of the sand fly. Keeping these things in mind “Integrated vector control” is adopted under National vector borne disease control programme as one of the strategies to bring down the disease burden.
format Online
Article
Text
id pubmed-8061485
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-80614852021-04-27 Epidemiology of Post-Kala-azar Dermal Leishmaniasis Ghosh, Pramit Roy, Pritam Chaudhuri, Surya Jyati Das, Nilay Kanti Indian J Dermatol IJD Symposium Post-kala-azar dermal leishmaniasis (PKDL) is a cutaneous sequel of visceral leishmaniasis (VL) or kala-azar and has become an entity of epidemiological significance by virtue of its ability to maintain the disease in circulation during inter-epidemic periods. PKDL has been identified as one of the epidemiological marker of “kala-azar elimination programme.” Data obtained in 2018 showed PKDL distribution primarily concentrated in 6 countries, which includes India, Sudan, south Sudan, Bangladesh, Ethiopia, and Nepal in decreasing order of case-burden. In India, PKDL cases are mainly found in 54 districts, of which 33 are in Bihar, 11 in West Bengal, 4 in Jharkhand, and 6 in Uttar Pradesh. In West Bengal the districts reporting cases of PKDL cases include Darjeeling, Uttar Dinajpur, Dakshin Dinajpur, Malda, and Murshidabad. The vulnerability on the young age is documented in various studies. The studies also highlights a male predominance of the disease but recent active surveillance suggested that macular form of PKDL shows female-predominance. It is recommended that along with passive case detection, active survey helps in early identification of cases, thus reducing disease transmission in the community. The Accelerated plan for Kala-azar elimination in 2017 introduced by Government of India with the goal to eliminate Kala-azar as a public health problem, targets to reduceing annual incidence <1/10,000. Leishmania donovani is the established causative agent, but others like L. tropica or L. infantum may occasionally lead to the disease, especially with HIV-co-infection. Dermal tropism of the parasite has been attributed to overexpression of parasite surface receptors (like gp 63, gp46). Various host factors are also identified to contribute to the development of the disease, including high pretreatment IL 10 and parasite level, inadequate dose and duration of treatment, malnutrition, immuno-suppression, decreased interferon-gamma receptor 1 gene, etc. PKDL is mostly concentrated in the plains below an altitude of 600 mts which is attributed to the environment conducive for the vector sand fly (Phlebotumus). Risk factors are also linked to the habitat of the sand fly. Keeping these things in mind “Integrated vector control” is adopted under National vector borne disease control programme as one of the strategies to bring down the disease burden. Wolters Kluwer - Medknow 2021 /pmc/articles/PMC8061485/ /pubmed/33911289 http://dx.doi.org/10.4103/ijd.IJD_651_20 Text en Copyright: © 2021 Indian Journal of Dermatology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle IJD Symposium
Ghosh, Pramit
Roy, Pritam
Chaudhuri, Surya Jyati
Das, Nilay Kanti
Epidemiology of Post-Kala-azar Dermal Leishmaniasis
title Epidemiology of Post-Kala-azar Dermal Leishmaniasis
title_full Epidemiology of Post-Kala-azar Dermal Leishmaniasis
title_fullStr Epidemiology of Post-Kala-azar Dermal Leishmaniasis
title_full_unstemmed Epidemiology of Post-Kala-azar Dermal Leishmaniasis
title_short Epidemiology of Post-Kala-azar Dermal Leishmaniasis
title_sort epidemiology of post-kala-azar dermal leishmaniasis
topic IJD Symposium
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061485/
https://www.ncbi.nlm.nih.gov/pubmed/33911289
http://dx.doi.org/10.4103/ijd.IJD_651_20
work_keys_str_mv AT ghoshpramit epidemiologyofpostkalaazardermalleishmaniasis
AT roypritam epidemiologyofpostkalaazardermalleishmaniasis
AT chaudhurisuryajyati epidemiologyofpostkalaazardermalleishmaniasis
AT dasnilaykanti epidemiologyofpostkalaazardermalleishmaniasis